Live Coronary Artery Disease updates

Live Coronary Artery Disease news coverage of developments with the latest updates. Stay on top of latest Coronary Artery Disease news stories and find out what just happened, what is going on with Coronary Artery Disease. The latest real-time news updates and headlines on Coronary Artery Disease
New Material Boosts Angiotensin II Test Accuracy
Shingles Pain Lingers: Scientists Uncover Causes
U.S., Vietnam Forge New Health Partnership
Research: Cancer Protein Binds Chromosome Unexpectedly
Parasite Diagnosis Key for Dog, Human Health
AI Model Powers Precision Lp
Landmark Study Redefines Rare Disorders
Liver Condition Affects 1 in 6 Women: Pregnancy Impact
Sudan Aid at Risk of Collapse, IOM Chief Warns
UNICEF Reaches Isolated Jonglei Communities in S. Sudan
Metabolic Weakness Linked to Heart Development
Blood Biomarker Tracks Lecanemab Response in Alzheimer's
Measles Case 14 September 2026
Aortic Structure Tied to Midlife Pulse Pressure Rise
Airway Bacteria Influence Pollution Health Risk
Probing Origins of Childhood Cancer Tumors
Enhertu Shows 14.3-Month PFS in HER2+ Lung Cancer Trial
Tagrisso Achieves 8-Year Survival in EGFR Lung Cancer
BC Decriminalization Cuts Drug Arrests, Deaths Unchanged
Meningococcal Case 14 September 2026
Scientists Target Gum Disease With Virus
KAIST Team Reveals Neuron RNA Delivery Mechanism
Amivantamab-Chemo Yields Best Survival in EGFR NSCLC
Eight-Year ADAURA Update: Osimertinib Boosts Survival
Trastuzumab Deruxtecan Boosts Survival in HER2 Lung Cancer
Fatigue Often Missed as Liver Disease Signal
$14M Partnership to Enhance Drought Resilience in Australia
Winter Rain Tops Up SA Rural Confidence
PBS Adds First Biologic for Uncontrolled COPD
MAVERICK Trial Backs Brain MRI Alone for Lung Cancer
Phase III TAISHAN-302: Tam-Peli Boosts Survival in SCLC
ARTEMIS-008: Risvutatug Boosts Survival in Lung Cancer
Sacituzumab, Pembrolizumab Combo Misses NSCLC Targets
Pumitamig Plus Elfetabart Shows Promise in Lung Cancer
Therapy Fails to Boost Survival After Dual Immunotherapy
Atezolizumab Combo Doubles Event-Free Survival in NSCLC
Subcutaneous Tarlatamab Safe, Effective in SCLC Trial
Bacteria Colonies Spread Swiftly Through Fluid Flow
Two More H5 Bird Flu Cases Hit NSW Central, South Coast
Bird Flu - What You Need To Know
Diagnostics Target Hit, Waitlists Drop 21%
SERENA-4 Trial: Etcamah, Palbociclib in ER+ Breast Cancer
CU Anschutz Advances Precision Medicine for Rare Cancers
New Disease Causes Night Blindness, Vision Loss
Rare Neurons Found: Key to Inducing Brain Sleep
Bone Marrow-on-a-Chip Model Studies Immune Cells
UC Davis Lands $23M NIH Grant for Alzheimer's Research
Ameloblastin Helix Guides Tooth Enamel Formation